Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
Sharmila Nair, Luciano Mazzoccoli, Arijita Jash, et al.
JCI Insight (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Adel Naimi, Rebar N. Mohammed, Ahmed Raji, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 283
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
Somayeh Vafaei, Angelina Olegovna Zekiy, Ramadhan Ado Khanamir, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 170
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
Masmudur M. Rahman, Grant McFadden
Cancers (2021) Vol. 13, Iss. 21, pp. 5452-5452
Open Access | Times Cited: 111
Signaling pathways in brain tumors and therapeutic interventions
Shenglan Li, Can Wang, Jinyi Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
Simona Ruxandra Volovăț, Dragoş Viorel Scripcariu, Ingrid-Andrada Vasilache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1180-1180
Open Access | Times Cited: 20
Advanced drug delivery platforms target cancer stem cells
MirAhmad Mazloomi, Abolfazl Doustmihan, Sajjad Alimohammadvand, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101036-101036
Open Access | Times Cited: 3
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
Jiayi Zeng, Xiangxue Li, Max Sander, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 64
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
Daniel Kreatsoulas, Chelsea Bolyard, Bill X. Wu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 49
Using mass spectrometry imaging to map fluxes quantitatively in the tumor ecosystem
Michaela Schwaiger-Haber, Ethan Stancliffe, Dhanalakshmi S. Anbukumar, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
Yi-Ying Wu, Te-Kai Sun, Ming‐Shan Chen, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 32
Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
Palaniyandi Muthukutty, So Young Yoo
Viruses (2023) Vol. 15, Iss. 8, pp. 1645-1645
Open Access | Times Cited: 25
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 15
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 13
T lymphocytes as dynamic regulators of glioma pathobiology
Elizabeth Cordell, Mahmoud S. Alghamri, María G. Castro, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 10, pp. 1647-1657
Open Access | Times Cited: 31
Glioblastoma microenvironment—from biology to therapy
Renee Read, Zoe M. Tapp, Prajwal Rajappa, et al.
Genes & Development (2024)
Open Access | Times Cited: 6
Apoptosis during ZIKA Virus Infection: Too Soon or Too Late?
Jonathan Turpin, Daed El Safadi, Grégorie Lebeau, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1287-1287
Open Access | Times Cited: 23
Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy
Xianwang Wang, Yihua Shen, Xingxia Wan, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner
Joseph Mazar, Jeanne K. Brooks, Matthew Peloquin, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 1, pp. 65-80
Open Access | Times Cited: 5
Novel Clinical Trials and Approaches in the Management of Glioblastoma
Allison R. Valerius, Lauren M. Webb, Uğur Sener
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 439-465
Closed Access | Times Cited: 5
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model
Moritz Klawitter, Ali El-Ayoubi, Jasmin Buch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9965-9965
Open Access | Times Cited: 19
Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
Zhongbing Qi, Xiangyu Long, Jiyan Liu, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 19
Zika virus cleaves GSDMD to disseminate prognosticable and controllable oncolysis in a human glioblastoma cell model
Yu-Ting Kao, Hsin-I Wang, Chi-Ting Shie, et al.
Molecular Therapy — Oncolytics (2023) Vol. 28, pp. 104-117
Open Access | Times Cited: 12
Oncolytic virus therapy for malignant gliomas: entering the new era
Hirotaka Fudaba, Hiroaki Wakimoto
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 3, pp. 269-282
Closed Access | Times Cited: 12
Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells
Carla Bianca Luena Victorio, Wisna Novera, Arun Ganasarajah, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas
Georgios M. Stergiopoulos, Susanna C. Concilio, Evanthia Galanis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 7, pp. 952-991
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top